Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03360214 · ClinicalTrials.gov registry record · Phase 4
PEMF and PEC Blocks in Mastectomy Reconstruction Patients
A Phase 4 study, sponsored by Columbia University.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT03360214 is a Phase 4 study that has completed, run by Columbia University. The registered enrollment target is 60 participants.
The verdict
NCT03360214, a Phase 4 study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
This is a prospective randomized controlled double-blind interventional study comparing the effect of pulsed-electromagnetic field device (PEMF), pectoral interfascial block (PIB), and placebo on postoperative pain control. This study has the interdisciplinary cooperation of the regional anesthesia group, and the breast and plastic surgery divisions. All female patients with breast cancer evaluated at Columbia University Medical Center (CUMC) who are undergoing unilateral or bilateral mastectomy with tissue expander reconstruction will be offered enrollment in this prospective study.
Interventions
- OTHER Placebo Drug
- DRUG Bupivacaine Hydrochloride
- DEVICE Pulsed Electromagnetic Field (PEMF) Device
- OTHER Placebo Device
- DRUG Ropivacaine Hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2017-07-05 |
| Est. Completion | 2022-03-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03360214
The ClinicalTrials.gov registry entry for NCT03360214 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Placebo Drug is the first listed.
NCT03360214 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03360214 about?
NCT03360214 is a clinical study titled "PEMF and PEC Blocks in Mastectomy Reconstruction Patients". This is a prospective randomized controlled double-blind interventional study comparing the effect of pulsed-electromagnetic field device (PEMF), pectoral interfascial block (PIB), and placebo on postoperative pain control. This study has the interdisciplinary cooperation of the regional anesthesia ...
What is the current status of trial NCT03360214?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2017-07-05. Estimated completion is 2022-03-07.
What interventions are being tested in trial NCT03360214?
The interventions under investigation include: Placebo Drug (OTHER), Bupivacaine Hydrochloride (DRUG), Pulsed Electromagnetic Field (PEMF) Device (DEVICE), Placebo Device (OTHER), Ropivacaine Hydrochloride (DRUG).
Who is sponsoring clinical trial NCT03360214?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.